For instance, fisetin controls miR-3664-3p expression in HCT116 cells, thereby decreasing drug resistance of colorectal cancer cells by targeting ABCG2, CYP3A4, MCL1, and MLH1 [56]. This evidence concerns the gene ABCG2 and colorectal cancer.